24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Epinephrine
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:23
Revolut, Rapyd, Mesh, and Airwallex win payment licenses in Israel
10:07
Israel’s long arm of air power faces new crossroads
09:37
How Square Peg outpaces the VC pack: “Every team member has an AI mindset”
09:36
Why Horizon Capital expects $1M ARR from $1M Pre-Seed in 18 months
More stories
Buzz
Most popular
Daily
Weekly
1
Is Palo Alto Networks eyeing a SentinelOne takeover?
2
Datadog in talks to acquire Upwind for $1 billion
3
Wave of Israeli AI-Cyber exits looms as buyers circle
4
Daylight Security raises $7M in Seed funding to combine AI agents and human experts in cyber defense
5
Intel’s optimistic Israel plans clash with brutal job cuts
More news
Epinephrine
1 stories about Epinephrine
Teva, Mylan Drop on Announcement of Epinephrine Injector Rival
09.12.18
|
Lilach Baumer
Novartis’ U.S. division Sandoz announced a planned release for early 2019. The company will sell its drug, which lacks the EpiPen’s auto-injector, for $250 a pair out of pocket, compared to Mylan and Teva’s $300
